Elsayed Soliman to Spironolactone
This is a "connection" page, showing publications Elsayed Soliman has written about Spironolactone.
Connection Strength
1.327
-
O'Neal WT, Sandesara PB, Samman-Tahhan A, Kelli HM, Hammadah M, Soliman EZ. Heart rate and the risk of adverse outcomes in patients with heart failure with preserved ejection fraction. Eur J Prev Cardiol. 2017 07; 24(11):1212-1219.
Score: 0.592
-
O'Neal WT, Sandesara P, Hammadah M, Venkatesh S, Samman-Tahhan A, Kelli HM, Soliman EZ. Gender Differences in the Risk of Adverse Outcomes in Patients With Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction. Am J Cardiol. 2017 06 01; 119(11):1785-1790.
Score: 0.586
-
O'Neal WT, Sandesara P, Patel N, Venkatesh S, Samman-Tahhan A, Hammadah M, Kelli HM, Soliman EZ. Echocardiographic predictors of atrial fibrillation in patients with heart failure with preserved ejection fraction. Eur Heart J Cardiovasc Imaging. 2017 Jul 01; 18(7):725-729.
Score: 0.149